Schedule 13D ownership disclosure
Stealth BioTherapeutics Corp
Security class unavailable · CUSIP: 85788D100
Event date: 2021-12-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 581,383,192
- Percent of class
- 68.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-148589
- Form type
- SC 13D
- Filer
- Morningside Venture (I) Investments Ltd
- CIK
- CIK 1770194
- Filed
- Dec 10, 2021
- Reporting period
- Dec 01, 2021
- Description
- Schedule 13D beneficial ownership